Libo Chen

443 total citations
21 papers, 299 citations indexed

About

Libo Chen is a scholar working on Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Libo Chen has authored 21 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Molecular Biology. Recurrent topics in Libo Chen's work include Thyroid Cancer Diagnosis and Treatment (18 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Medical Imaging Techniques and Applications (4 papers). Libo Chen is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (18 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Medical Imaging Techniques and Applications (4 papers). Libo Chen collaborates with scholars based in China, United States and United Kingdom. Libo Chen's co-authors include Yuchen Jin, Min Liu, Maomei Ruan, Lin Cheng, Hao Fu, Qianggang Dong, Zhiyan Liu, Rui Liang, Hankui Lu and Ruisen Zhu and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes and Scientific Reports.

In The Last Decade

Libo Chen

20 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Libo Chen China 11 213 109 58 58 56 21 299
Songfeng Wei China 10 208 1.0× 157 1.4× 84 1.4× 52 0.9× 31 0.6× 23 360
Libo Chen China 10 216 1.0× 69 0.6× 52 0.9× 58 1.0× 49 0.9× 26 295
Rong-Liang Shi China 12 191 0.9× 145 1.3× 95 1.6× 78 1.3× 28 0.5× 15 384
Yanan Xu China 8 127 0.6× 118 1.1× 75 1.3× 56 1.0× 16 0.3× 14 287
Tomasz Trybek Poland 11 205 1.0× 102 0.9× 60 1.0× 57 1.0× 30 0.5× 16 313
Patricia Borges de Souza Italy 7 223 1.0× 119 1.1× 36 0.6× 84 1.4× 27 0.5× 12 367
Carmela Coccaro Italy 11 224 1.1× 56 0.5× 83 1.4× 56 1.0× 64 1.1× 17 305
Carla Vaz Ferreira Brazil 8 215 1.0× 77 0.7× 60 1.0× 65 1.1× 15 0.3× 11 280
Hans H G Verbeek Netherlands 5 195 0.9× 41 0.4× 73 1.3× 66 1.1× 36 0.6× 10 242
Teresa Ramone Italy 9 297 1.4× 77 0.7× 53 0.9× 103 1.8× 27 0.5× 23 352

Countries citing papers authored by Libo Chen

Since Specialization
Citations

This map shows the geographic impact of Libo Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libo Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libo Chen more than expected).

Fields of papers citing papers by Libo Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Libo Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libo Chen. The network helps show where Libo Chen may publish in the future.

Co-authorship network of co-authors of Libo Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Libo Chen. A scholar is included among the top collaborators of Libo Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Libo Chen. Libo Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Yansong, Renfei Wang, Rui Huang, et al.. (2025). Chinese management guidelines for radioactive iodine-refractory differentiated thyroid cancer (2025 edition). European Journal of Nuclear Medicine and Molecular Imaging. 52(10). 3859–3876. 2 indexed citations
2.
3.
4.
Jin, Yuchen, et al.. (2022). ERBB2 as a prognostic biomarker correlates with immune infiltrates in papillary thyroid cancer. Frontiers in Genetics. 13. 966365–966365. 3 indexed citations
5.
Cheng, Lin, et al.. (2022). Initial or salvage treatment with apatinib shows promise against radioiodine-refractory differentiated thyroid carcinoma. European Thyroid Journal. 11(2). 3 indexed citations
6.
7.
Cheng, Lin, Qiong Luo, Hao Fu, et al.. (2020). Unexplained Hyperthyroglobulinemia in Differentiated Thyroid Cancer Patients as an Indication for Radioiodine Adjuvant Therapy: A Prospective Multicenter Study. Journal of Nuclear Medicine. 62(1). 62–68. 14 indexed citations
8.
Fu, Hao, et al.. (2020). Updated Review of Nuclear Molecular Imaging of Thyroid Cancers. Endocrine Practice. 27(5). 494–502. 8 indexed citations
9.
10.
Cheng, Lin, Qiong Jiao, Yuchen Jin, et al.. (2019). <p>Initial Therapy of Advanced Anaplastic Thyroid Cancer via Targeting VEGFR-2: A Case Report</p>. OncoTargets and Therapy. Volume 12. 10495–10500. 3 indexed citations
11.
Fu, Hao, et al.. (2019). MAPK Inhibitors Enhance HDAC Inhibitor-Induced Redifferentiation in Papillary Thyroid Cancer Cells Harboring BRAFV600E: An In Vitro Study. Molecular Therapy — Oncolytics. 12. 235–245. 38 indexed citations
12.
13.
Jin, Yuchen, et al.. (2018). False-Positive Uptake of 131I Due to Tubal Ligation in a Patient With Papillary Thyroid Cancer. Clinical Nuclear Medicine. 43(5). 375–376. 2 indexed citations
14.
Jin, Yuchen, et al.. (2017). HER inhibitor promotes BRAF/MEK inhibitor-induced redifferentiation in papillary thyroid cancer harboring BRAFV600E. Oncotarget. 8(12). 19843–19854. 45 indexed citations
15.
Liu, Min, et al.. (2017). 99mTc-pertechnetate-avid metastases from differentiated thyroid cancer are prone to benefit from 131I therapy. Medicine. 96(33). e7631–e7631. 9 indexed citations
16.
Liu, Min, et al.. (2016). Challenges and strategies on radioiodine treatment for differentiated thyroid carcinoma.. PubMed. 19(1). 23–32. 10 indexed citations
17.
Shen, Yan, Jianding Ye, Wentao Fang, et al.. (2016). Efficacy of computed tomography features in predicting stage III thymic tumors. Oncology Letters. 13(1). 29–36. 5 indexed citations
18.
Ruan, Maomei, Min Liu, Qianggang Dong, & Libo Chen. (2015). Iodide- and Glucose-Handling Gene Expression Regulated by Sorafenib or Cabozantinib in Papillary Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 100(5). 1771–1779. 24 indexed citations
19.
Ruan, Maomei, Yan Shen, Libo Chen, & Ming‐Hua Li. (2013). RECIST 1.1 and serum thyroglobulin measurements in the evaluation of responses to sorafenib in patients with radioactive iodine-refractory differentiated thyroid carcinoma. Oncology Letters. 6(2). 480–486. 11 indexed citations
20.
Lu, Hankui, et al.. (2008). Comparison of free plasma metanephrines enzyme immunoassay with 131I-MIBG scan in diagnosis of pheochromocytoma. Clinical and Experimental Medicine. 8(2). 87–91. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Songfeng Wei Breakdown of academic impact, for papers by Libo Chen Breakdown of academic impact, for papers by Rong-Liang Shi Breakdown of academic impact, for papers by Yanan Xu Breakdown of academic impact, for papers by Tomasz Trybek Breakdown of academic impact, for papers by Patricia Borges de Souza Breakdown of academic impact, for papers by Carmela Coccaro Breakdown of academic impact, for papers by Carla Vaz Ferreira Breakdown of academic impact, for papers by Hans H G Verbeek Breakdown of academic impact, for papers by Teresa Ramone
Rankless by CCL
2026